Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| PROSAT WIPES WITH CYQUANOL | CONTEC INCORPORATED | Marketed | Jan 1, 2025 | Marketed |
| CONTEC CYQUANOL | CONTEC INCORPORATED | Marketed | Jan 1, 2025 | Marketed |
| ISLAND SPORT FACE SWEAT RESISTANT SUNSCREEN SPRITZ SPF 30 | edgewell personal care canada, ulc | Marketed | Jan 1, 2025 | Marketed |
| ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRITZ SPF 30 | edgewell personal care canada, ulc | Marketed | Jan 1, 2025 | Marketed |
| MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH | crls | Marketed | Dec 30, 2024 | Marketed |
| MUCUS & PHLEGM RELIEF EXTRA STRENGTH | crls | Marketed | Dec 30, 2024 | Marketed |
| COUGH & CHEST CONGESTION EXTRA STRENGTH | crls | Marketed | Dec 30, 2024 | Marketed |
| BRIGHT REVEAL SPF50+ | l' oreal canada | Marketed | Dec 28, 2024 | Marketed |
| CHLORAPREP SWABSTICKS | becton dickinson canada inc. | Marketed | Dec 24, 2024 | Marketed |
| M-RIVAROXABAN | mantra pharma inc | Marketed | Dec 19, 2024 | Marketed |
| M-RIVAROXABAN | mantra pharma inc | Marketed | Dec 19, 2024 | Marketed |
| M-RIVAROXABAN | mantra pharma inc | Marketed | Dec 19, 2024 | Marketed |
| M-RIVAROXABAN | mantra pharma inc | Marketed | Dec 19, 2024 | Marketed |
| MIEBO | bausch & lomb inc | Marketed | Dec 18, 2024 | Marketed |
| SITAGLIPTIN | sanis health inc | Marketed | Dec 17, 2024 | Marketed |
| AG-LEVOCARB | angita pharma inc. | Marketed | Dec 17, 2024 | Marketed |
| LURASIDONE | sanis health inc | Marketed | Dec 17, 2024 | Marketed |
| SITAGLIPTIN | sanis health inc | Marketed | Dec 17, 2024 | Marketed |
| LURASIDONE | sanis health inc | Marketed | Dec 17, 2024 | Marketed |
| LURASIDONE | sanis health inc | Marketed | Dec 17, 2024 | Marketed |
